BOSULIF

Bosulif 100mg, 400mg, 500mg Prescribing Information

PP-BOS-ISR-0112

Thank you for being interested in receiving more information!
You will soon be leaving Pfizer.co.il.
Pfizer bears no responsibility for the content of external websites or in connection with the information provided by them. Pfizer does not accept any liability in connection to any information these websites provide.

Continue Cancel

September 2023

PP-BOS-ISR-0112

The information provided on this website is intended for health care professionals in Israel only.

Privacy policy
Cookie policy
Terms of use for professional staff
Accessibility statement

Sponsored by Pfizer.
Pfizer Pharmaceuticals Israel Ltd. Is registered in Israel under private company no. 512092115. Pfizer PFE Pharmaceuticals Israel Ltd. Is registered in Israel under private company no. 515105385.
All rights reserved ©. Our address: 9 Shenkar Street, Herzliya.
For questions about the company, its commercial operations in the healthcare field or to receive information about the company’s medications, please contact Pfizer Pharmaceuticals Israel Ltd.
At Tel 972-9-970-0500 or by e-mail [email protected]

To report side effects: [email protected] | To report quality complaints: [email protected] | For inquiries regarding medical information: [email protected]
For Ministry of Health side effect reporting: www.sideeffects.health.gov.il

Tel 972-9-970-0500 | Fax 972-9-970-0501 | Website pfizer.co.il

PP-UNP-ISR-0036

September 2023

BOSULIF

Bosulif Best Practice

Bosulif Contact Persons

Bosulif 100mg, 400mg, 500mg Prescribing Information